All-cause and Diseases-specific Mortality of High-risk HPV Infection

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06631495

Enrollment

100000

Registered

2024-10-08

Start date

2024-10-01

Completion date

2027-10-01

Last updated

2024-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HPV Infection

Brief summary

The corresponding prevention strategies and treatment routes of HPV infection can be provided through investigating causes of death due to HPV infection and specialized diseases.

Detailed description

Anxiety and panic about HPV infection have become common phenomena in tumor screening. Transitional and useless diagnosis and treatment caused by HPV infection are also common, affecting women's physical and mental health and health economic level. If the investigators can understand the causes of death related to HPV infection and specialized diseases, the investigators can provide corresponding prevention strategies and treatment routes from the level of health policies and individual methods and mechanisms, and also alleviate the related panic caused by HPV infection.

Interventions

OTHERObservation

not available-observation study

Study design

Observational model

CASE_ONLY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

1. Female participate in at least once cervical cancer screening with clear information of HPV DNA test results; 2. Having clear identification (ID number or others) that can be retrieved in the cause of death database.

Exclusion criteria

Cases that do not fully meet all inclusion criteria are used as

Design outcomes

Primary

Measure	Time frame	Description
HR-HPV infection AND all-cause and diseases-specific mortality	one year	all-cause and diseases-specific mortality of HR-HPV infection

Secondary

Measure	Time frame	Description
time-period of HR-HPV infection AND all-cause and diseases-specific mortality	one year	all-cause and diseases-specific mortality of time-period of HR-HPV infection
HR-HPV type AND all-cause and diseases-specific mortality	one year	all-cause and diseases-specific mortality of HR-HPV type

Countries

China

Contacts

Primary ContactLi, doctor

lileigh@163.com13911988831

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026